Join
Live feed
·
INSIDERFilingvia Quantisnow
Cartesian Therapeutics Inc. logo

Chief Financial Officer Davis Blaine sold $72,227 worth of Common Stock (10,591 units at $6.82), decreasing direct ownership by 8% to 121,220 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RNAC· Cartesian Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNAC (Cartesian Therapeutics Inc.) and more on Quantisnow.